483
Glenmark Pharmaceuticals Inc USAFDA 483 - Glenmark Pharmaceuticals Inc USA - July 26, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Glenmark Pharmaceuticals Inc., USA in Monroe, NC, revealed a significant issue regarding the prevention of microbiological contamination in sterile drug products. The firm failed to establish procedures for the periodic re-certification of HEPA filters, which is critical for maintaining air quality in controlled environments. This deficiency could compromise the sterility of their drug products.
- Office
- Atlanta District Office
- Person
Open in Dashboard
ID · a0d148ad-00b7-4e0e-b4b8-7335fd1e7280